Exton, PA · Founded 2015 · Privately Held (backing)
Developer of a fibroblast based therepy designed to treat rare and serious genetic diseases. Castle Creek Biosciences is based in Exton, PA and was founded in 2015. It has raised $419 million across 4 recorded rounds; the latest was a $75 million later-stage round in Feb 2025.
PMV mark · valuation
—
Oct 2026
Priced at
—
Total raised
$419.4M
Last round
Later Stage VC
Feb 2025
Team — not yet on record
No current team members for Castle Creek Biosciences are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Castle Creek Biosciences with a free account
·Watch Castle Creek Biosciences: the Monday email on marks, rounds and moves
